A 68-year-old woman from Delhi with a 10-year history of cirrhosis (Child-Pugh Class B, HBsAg positive) undergoes routine surveillance ultrasound. A 2.5 cm nodule is detected in the right lobe of the liver. Contrast-enhanced CT shows arterial phase enhancement with washout in the portal venous phase, consistent with hepatocellular carcinoma. Serum AFP is 450 ng/mL (normal <20 ng/mL). She is counseled about treatment options. Which of the following statements about AFP in hepatocellular carcinoma is MOST accurate?

Explanation

## AFP in Hepatocellular Carcinoma: Sensitivity, Specificity, and Clinical Role This question tests understanding of AFP's diagnostic and prognostic utility in HCC—a high-yield topic for NEET PG. ## AFP Sensitivity and Specificity in HCC **High-Yield:** AFP is elevated in **60–70%** of HCC cases, making it a useful but imperfect marker. Sensitivity varies by tumor size and stage: | HCC Stage/Size | AFP Elevation Rate | | --- | --- | | **Small HCC (<2 cm)** | ~30–40% | | **Intermediate HCC (2–5 cm)** | ~60–70% | | **Advanced HCC (>5 cm)** | ~80–90% | | **Overall HCC** | 60–70% | **Key Point:** AFP is a marker of **tumor burden and aggressiveness**, not diagnosis alone. Imaging (CT/MRI with arterial enhancement and washout) is required for diagnosis. ## Prognostic Significance ### AFP Levels and Prognosis | AFP Level | Prognostic Implication | | --- | --- | | **<20 ng/mL** | Normal; better prognosis | | **20–400 ng/mL** | Intermediate risk | | **>400 ng/mL** | High risk; advanced disease; poor prognosis | | **>1000 ng/mL** | Very high risk; often indicates vascular invasion or metastasis | **Clinical Pearl:** In this patient, AFP of 450 ng/mL (>400) indicates aggressive biology and higher risk of vascular invasion, despite the nodule being only 2.5 cm. This influences treatment selection (e.g., sorafenib for advanced disease vs. resection/transplant for early disease). ### AFP Dynamics - **Declining AFP** during treatment = good response - **Rising AFP** = progression or recurrence - **Rapid doubling** = poor prognostic sign ## Diagnostic Criteria for HCC (AASLD/EASL) **Mnemonic:** **IMAGING + AFP** — HCC diagnosis in cirrhotic patients: 1. **Nodule <10 mm:** Surveillance only 2. **Nodule 10–20 mm:** Requires 2 imaging modalities showing arterial enhancement + washout, OR 1 imaging + AFP >400 ng/mL 3. **Nodule >20 mm:** Requires 1 imaging modality showing arterial enhancement + washout, OR AFP >400 ng/mL + 1 imaging finding **Key Point:** AFP alone is **never diagnostic**—imaging confirmation is mandatory. In this patient, the imaging findings (arterial enhancement + washout) are diagnostic; AFP adds prognostic information. ## Why AFP is Not Specific **Warning:** AFP can be elevated in: - **Benign liver disease:** Cirrhosis, chronic hepatitis B/C, alcoholic liver disease - **Other malignancies:** Gastric cancer, pancreatic cancer, germ cell tumors, lung cancer - **Pregnancy:** Physiologically elevated Thus, AFP is **sensitive but not specific** for HCC. ## Clinical Application in This Case This patient has: - ✓ Cirrhosis (risk factor) - ✓ Imaging findings diagnostic of HCC (arterial enhancement + washout) - ✓ Elevated AFP (450 ng/mL) → indicates **aggressive tumor biology** and **poor prognosis** The elevated AFP does NOT diagnose HCC (imaging does), but it **stratifies risk** and guides treatment intensity. [cite:Harrison 21e Ch 297; Robbins 10e Ch 17]